ABBEY HOUSE PHARMACY (DAVENTRY) LIMITED

Accounts Submitted 15 Dec 2025

Confirmation Statement Submitted 6 Jan 2025

Net assets £295.64K £24.89K 2023 year on year

Total assets £460.19K £32.37K 2023 year on year

Total Liabilities £164.55K £7.48K 2023 year on year

Charges 1

1 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Leafield Estate Stratford Road Warwick Warwickshire CV34 6RA England

Credit Report

Discover ABBEY HOUSE PHARMACY (DAVENTRY) LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£280.02k

Increased by £40.14k (+17%)

Net Assets

£295.64k

Increased by £24.89k (+9%)

Total Liabilities

£164.55k

Increased by £7.48k (+5%)

Turnover

N/A

Employees

Increased by 1 (+8%)

Debt Ratio

36%

Decreased by 1 (-3%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 7 resigned

Show resigned officers

						Status
Christopher John Taylor	Secretary	British	Unknown	—	1 Apr 2008	Active
Michael James Taylor	Director	British	England	68	4 Apr 2008	Active

Shareholders

Shareholders (4)


Dt Sub 2 Limited	49.5%	99	B Ordinary	6 Jan 2025
Dt Sub 2 Limited	0.5%	1	Ordinary	6 Jan 2025
Patricia Susan Gardiner Nigel Brown	0.0%	0	A Ordinary	6 Jan 2025

Persons with Significant Control

Persons with Significant Control (3)

3 Active 3 Ceased

Dt Sub 2 Limited

United Kingdom

Active

Notified 20 Jul 2020

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors

Bryta Investments Limited

United Kingdom

Active

Notified 31 Jan 2024

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent

Michael James Taylor

British

Active

Notified 6 Apr 2016

Residence England

DOB March 1957

Nature of Control

Significant Influence Or Control

Patricia Susan Gardiner

Ceased 31 Jan 2024

Ceased

Dudley Taylor Pharmacies Limited

Ceased 20 Jul 2020

Ceased

Nigel Brown

Ceased 1 Jan 2020

Ceased

See All Controllers

Group Structure

DT SUB 2 LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

BRYTA INVESTMENTS LIMITED united kingdom

DUDLEY TAYLOR LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

DT SUB 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

DT NEWCO 3 LIMITED united kingdom

DT NEWCO 2 LIMITED united kingdom

ABBEY HOUSE PHARMACY (DAVENTRY) LIMITED Current Company

Charges

1 satisfied

Documents

Company Filings

Date	Category	Description	Document
15 Dec 2025	Accounts	Annual accounts made up to 2025-03-31	View(8 pages)
6 Jan 2025	Confirmation Statement	Confirmation statement made on 2024-12-31 with updates	View(5 pages)
19 Dec 2024	Accounts	Annual accounts made up to 2024-03-31	View(8 pages)
23 Feb 2024	Officers	Termination of Matthew Graham Davies as director on 2024-01-31	View(1 page)
23 Feb 2024	Persons With Significant Control	Bryta Investments Limited notified as a person with significant control	View(2 pages)